Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tullis Health Investors is a venture capital firm based in Palm Beach Gardens, Florida, focused on healthcare investments. Founded to target high-growth companies, the firm manages investments in medical devices, healthcare technology, specialty pharmaceuticals, and biotechnology. They emphasize minimizing regulatory and technology development risks.
The firm specializes in investing in commercial-stage healthcare companies, particularly those with novel and differentiated technologies. Tullis Health Investors targets sectors such as medical devices, healthcare services, specialty pharmaceuticals, and biotechnology, aiming for high-growth opportunities in large addressable markets.
Tullis Health Investors has backed notable companies including Alphatec Spine, Inc., a medical device company focused on spine surgery solutions; electroCore, Inc., which utilizes non-invasive vagus nerve stimulation technology; and Exagen, Inc., a provider of autoimmune testing. They also invested in Genoptix, Inc. (Exited, acquired by Novartis), Adams Respiratory Therapeutics, Inc. (Exited, acquired by Reckitt Benckiser), and Atritech, Inc. (Exited, acquired by Boston Scientific).
Email your pitch deck to deals@tullisfunds.com for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.